241 related articles for article (PubMed ID: 15000919)
1. First-trimester tests for trisomies 21 and 18 as sensitive as triple screen.
Lewis PR; Pasalio R
J Fam Pract; 2004 Mar; 53(3):184-6. PubMed ID: 15000919
[No Abstract] [Full Text] [Related]
2. Follow up and evaluation of the Victorian first-trimester combined screening programme for Down syndrome and trisomy 18.
Jaques AM; Halliday JL; Francis I; Bonacquisto L; Forbes R; Cronin A; Sheffield LJ
BJOG; 2007 Jul; 114(7):812-8. PubMed ID: 17501960
[TBL] [Abstract][Full Text] [Related]
3. Integrated screening for Down's syndrome.
Chen FM
J Fam Pract; 1999 Nov; 48(11):846-7. PubMed ID: 10907617
[No Abstract] [Full Text] [Related]
4. Screening for trisomy 18 by maternal age, fetal nuchal translucency, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
Kagan KO; Wright D; Maiz N; Pandeva I; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Sep; 32(4):488-92. PubMed ID: 18726925
[TBL] [Abstract][Full Text] [Related]
5. First-trimester screening for Down's syndrome.
Wald NJ
N Engl J Med; 2004 Feb; 350(6):619-21; author reply 619-21. PubMed ID: 14762194
[No Abstract] [Full Text] [Related]
6. Triploidy identified through second-trimester serum screening.
Huang T; Alberman E; Wald N; Summers AM
Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
[TBL] [Abstract][Full Text] [Related]
7. [The prenatal detection of trisomy 13, 18, and 21: comparison of the advanced first trimester screening (AFS) with the first trimester screening according to Nicolaides].
Hörmansdörfer C; Schmidt P; Hillemanns P; Scharf A
Z Geburtshilfe Neonatol; 2007 Dec; 211(6):243-9. PubMed ID: 18176905
[TBL] [Abstract][Full Text] [Related]
8. First- and second-trimester screening: detection of aneuploidies other than Down syndrome.
Breathnach FM; Malone FD; Lambert-Messerlian G; Cuckle HS; Porter TF; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Klugman S; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Tripp T; Bianchi DW; D'Alton ME;
Obstet Gynecol; 2007 Sep; 110(3):651-7. PubMed ID: 17766613
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in maternal serum screening for Down syndrome.
Messerlian GM; Canick JA
Med Health R I; 2002 Dec; 85(12):362-5. PubMed ID: 12593353
[TBL] [Abstract][Full Text] [Related]
10. Sequential pathways of testing after first-trimester screening for trisomy 21.
Platt LD; Greene N; Johnson A; Zachary J; Thom E; Krantz D; Simpson JL; Silver RK; Snijders RJ; Goetzl L; Pergament E; Filkins K; Mahoney MJ; Hogge WA; Wilson RD; Mohide P; Hershey D; MacGregor S; Bahado-Singh R; Jackson LG; Wapner R;
Obstet Gynecol; 2004 Oct; 104(4):661-6. PubMed ID: 15458882
[TBL] [Abstract][Full Text] [Related]
11. Prenatal screening for Down syndrome.
Ogle RF; Chitty LS
Hosp Med; 1998 Aug; 59(8):632-6. PubMed ID: 9829057
[TBL] [Abstract][Full Text] [Related]
12. Fetal pyelectasis: does fetal gender modify the risk of major trisomies?
Bornstein E; Barnhard Y; Donnenfeld A; Ferber A; Divon MY
Obstet Gynecol; 2006 Apr; 107(4):877-9. PubMed ID: 16582126
[TBL] [Abstract][Full Text] [Related]
13. Maternal serum screening of Palestinian women in the West Bank.
Husseini A; Akkawi M
East Mediterr Health J; 2005 Jul; 11(4):824-7. PubMed ID: 16700399
[TBL] [Abstract][Full Text] [Related]
14. [Prenatal diagnosis of 95 cases by cytogenetic analysis of early chorionic villi].
Sun NH
Zhonghua Fu Chan Ke Za Zhi; 1987 Mar; 22(2):79-81, 125-6. PubMed ID: 2957181
[No Abstract] [Full Text] [Related]
15. An outcomes analysis of five prenatal screening strategies for trisomy 21 in women younger than 35 years.
Biggio JR; Morris TC; Owen J; Stringer JS
Am J Obstet Gynecol; 2004 Mar; 190(3):721-9. PubMed ID: 15042005
[TBL] [Abstract][Full Text] [Related]
16. The significance of a positive second trimester serum screen for trisomy 18.
Oyelese Y; Tobon L; Burton A; Adamczak J; Ashkinadze E; Smulian JC; Canterino J
J Matern Fetal Neonatal Med; 2010 Jul; 23(7):633-7. PubMed ID: 20540657
[TBL] [Abstract][Full Text] [Related]
17. Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18.
Sparks AB; Struble CA; Wang ET; Song K; Oliphant A
Am J Obstet Gynecol; 2012 Apr; 206(4):319.e1-9. PubMed ID: 22464072
[TBL] [Abstract][Full Text] [Related]
18. Combining first and second trimester markers for Down syndrome screening: think twice.
Cocciolone R; Brameld K; O'Leary P; Haan E; Muller P; Shand K
Aust N Z J Obstet Gynaecol; 2008 Oct; 48(5):492-500. PubMed ID: 19032666
[TBL] [Abstract][Full Text] [Related]
19. Is second-trimester genetic amniocentesis for trisomy 18 ever indicated in the presence of a normal genetic sonogram?
Oyelese Y; Vintzileos AM
Ultrasound Obstet Gynecol; 2005 Dec; 26(7):691-4. PubMed ID: 16308891
[No Abstract] [Full Text] [Related]
20. Screening for triploidy by the risk algorithms for trisomies 21, 18 and 13 at 11 weeks to 13 weeks and 6 days of gestation.
Kagan KO; Anderson JM; Anwandter G; Neksasova K; Nicolaides KH
Prenat Diagn; 2008 Dec; 28(13):1209-13. PubMed ID: 19039823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
